Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Clinical studies have shown that individuals using semaglutide experience a significant average weight loss of 14.9% within a year, with about one-third achieving an even more remarkable weight reduction exceeding 20% (PubMed)
In animal toxicology studies, no significant adverse effects have been observed even at doses far exceeding typical therapeutic ranges
Several trials are underway investigating dual- and triple-incretin agonists
*Alterra Health and its parent company Puente Holdings, LLC provide education, coaching, guides, support, and lifestyle programs
US$ 27.93
US$ 23.17
US$ 21.43
US$ 21.06
US$ 24.37
US$ 26.79
US$ 24.08
US$ 28.28
